Effect of a Physical Exercise Session Performed During a 24-34 Hour Fasting Period on Energy Metabolism and Cognitive Function in Healthy Adults (IMS)

December 18, 2025 updated by: Guillermo Sanchez Delgado, Universidad de Granada

Efecto de Una sesión de Ejercicio físico Realizada Durante un Periodo de Ayuno de 24-34 Horas Sobre el Metabolismo energético y la función Cognitiva en Adultos Sanos: Estudio Piloto

This study explores the impact of high-intensity exercise during fasting on energy metabolism and cognitive function in healthy adults. Changes in respiratory exchange ratio, blood substances, and cognitive performance will be measured after 24 and 34 hours of fasting with and without exercise in a randomized crossover design.

Study Overview

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Granada
      • Granada, Granada, Spain, 18007
        • Instiuto Mixto Universitario Deporte y Salud

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18-40 years old.
  • Body mass index: 18.5-30.0 Kg/m2.
  • Stable body weight (5kg range within the last 3 months)
  • Being able to consume all the food items provided as part of the study.
  • Not having change the time zone or have shifted sleeping hours equivalent to more than 3 hours on the previous 2 weeks.

Exclusion Criteria:

  • Diagnosed with any chronic condition that, in the research team's opinion or based on the American College of Sports Medicine guidelines, could contraindicate the implementation of 34-hour fasting periods and/or high-intensity exercise.
  • Diagnosed with a chronic endocrine, digestive, rheumatic, neurological, cardiac, pulmonary, autoimmune, or infectious condition that affects energy metabolism.
  • Presenting any signs or symptoms of illness that, in the research team's opinion or based on the American College of Sports Medicine guidelines, could contraindicate the implementation of 34-hour fasting periods and/or high-intensity exercise.
  • Pregnant or breastfeeding.
  • Using medications or supplements that may alter energy metabolism.
  • Currently undergoing or having undergone any type of nutritional intervention or treatment in the past 3 months.
  • Engaging in more than 5 hours per week of habitual moderate-to-vigorous cycling.
  • Any other condition that, in the research team's opinion, discourages participation in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Fasting, then fasting+exercise
Participants will fast for 34h after a standardized breakfast, refraining from physical activity.
Participants will fast for 34h after a standardized breakfast, performing a high-intensity exercise session 6-10 hours aprox. after starting the fasting period.
Experimental: Fasting + Exercise, then fasting
Participants will fast for 34h after a standardized breakfast, refraining from physical activity.
Participants will fast for 34h after a standardized breakfast, performing a high-intensity exercise session 6-10 hours aprox. after starting the fasting period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Respiratory Exchange Ratio
Time Frame: 24-hour after starting the fasting period
24-hour after starting the fasting period

Secondary Outcome Measures

Outcome Measure
Time Frame
Respiratory Exchange Ratio
Time Frame: 34-hour after starting the fasting period
34-hour after starting the fasting period
Serum insulin concentration
Time Frame: 24-hour after starting the fasting period
24-hour after starting the fasting period
Serum insulin concentration
Time Frame: 34-hour after starting the fasting period
34-hour after starting the fasting period
Serum glucose concentration
Time Frame: 24-hour after starting the fasting period
24-hour after starting the fasting period
Serum glucose concentration
Time Frame: 34-hour after starting the fasting period
34-hour after starting the fasting period
Dimensional Change Card Sort Test (NIH toolbox)
Time Frame: 24-hour after starting the fasting period
24-hour after starting the fasting period
Dimensional Change Card Sort Test (NIH toolbox)
Time Frame: 34-hour after starting the fasting period
34-hour after starting the fasting period
List Sorting Working Memory Test (NIH toolbox)
Time Frame: 24-hour after starting the fasting period
24-hour after starting the fasting period
List Sorting Working Memory Test (NIH toolbox)
Time Frame: 34-hour after starting the fasting period
34-hour after starting the fasting period
Flanker Test (NIH toolbox)
Time Frame: 24-hour after starting the fasting period
24-hour after starting the fasting period
Flanker Test (NIH toolbox)
Time Frame: 34-hour after starting the fasting period
34-hour after starting the fasting period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 29, 2023

Primary Completion (Actual)

June 11, 2025

Study Completion (Actual)

June 18, 2025

Study Registration Dates

First Submitted

June 5, 2023

First Submitted That Met QC Criteria

June 15, 2023

First Posted (Actual)

June 27, 2023

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 18, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • GSD-2023-002

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Energy Metabolism

Subscribe